YR, D., XJ, C., W, C., LF, W., HP, J., D, L., . . . SQ, G. (2021). Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum]. Dove Medical Press.
Cita Chicago Style (17a ed.)YR, Deng, Chen XJ, Chen W, Wu LF, Jiang HP, Lin D, Wang LJ, Wang W, y Guo SQ. Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum]. Dove Medical Press, 2021.
Cita MLA (8a ed.)YR, Deng, et al. Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum]. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.